drugset / Trial / NCT00049361

Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases

NCT00049361 ↗

Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor. Combining whole-brain radiation therapy with thalidomide and temozolomide may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining whole-brain radiation therapy with thalidomide and temozolomide in treating patients who have newly diagnosed brain metastases.

Timeline

Start
2004-01-01
Primary completion
2004-12-07
Completion
2004-12-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule — Oral
Subject Thalidomide Other / unclassified — Oral